- Home
- ITRM vs NUKK Comparison
ITRM vs NUKK Comparison
Compare ITRM & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- NUKK
- Stock Information
- Founded
- ITRM 2015
- NUKK 2013
- Country
- ITRM Ireland
- NUKK United States
- Employees
- ITRM N/A
- NUKK N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- NUKK Blank Checks
- Sector
- ITRM Health Care
- NUKK Finance
- Exchange
- ITRM Nasdaq
- NUKK Nasdaq
- Market Cap
- ITRM 40.0M
- NUKK 37.7M
- IPO Year
- ITRM 2018
- NUKK N/A
- Fundamental
- Price
- ITRM $0.77
- NUKK $8.30
- Analyst Decision
- ITRM Strong Buy
- NUKK
- Analyst Count
- ITRM 1
- NUKK 0
- Target Price
- ITRM $9.00
- NUKK N/A
- AVG Volume (30 Days)
- ITRM 739.9K
- NUKK 3.5M
- Earning Date
- ITRM 11-13-2025
- NUKK 11-14-2025
- Dividend Yield
- ITRM N/A
- NUKK N/A
- EPS Growth
- ITRM N/A
- NUKK N/A
- EPS
- ITRM N/A
- NUKK N/A
- Revenue
- ITRM N/A
- NUKK N/A
- Revenue This Year
- ITRM N/A
- NUKK N/A
- Revenue Next Year
- ITRM $482.25
- NUKK N/A
- P/E Ratio
- ITRM N/A
- NUKK N/A
- Revenue Growth
- ITRM N/A
- NUKK N/A
- 52 Week Low
- ITRM $0.61
- NUKK $1.30
- 52 Week High
- ITRM $3.02
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- ITRM 59.02
- NUKK 65.86
- Support Level
- ITRM $0.66
- NUKK $5.18
- Resistance Level
- ITRM $0.81
- NUKK $9.70
- Average True Range (ATR)
- ITRM 0.05
- NUKK 0.93
- MACD
- ITRM 0.01
- NUKK 0.34
- Stochastic Oscillator
- ITRM 63.76
- NUKK 71.26
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).